V. I. Prohorova

Determination of the Risk of Tumor Progression in Patients with Early Stages of Adenocarcinoma and Squamous Cell Lung Carcinoma Based on Laboratory Parameters

A. Tahanovich, N. Kauhanka, V. I. Prohorova, 2022, Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry.

Rationale importance of integrated determination of the level of CYFRA 21-1 and the receptors CXCR1, CXCR2, CD44v6 in the blood of patients with early-stage non-small cell lung cancer for predicting the tumor progression risk

A. Tahanovich, N. Kauhanka, V. I. Prohorova, 2022, Proceedings of the National Academy of Sciences of Belarus, Medical series.